PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, supplying promising advancements across a variety of health-related and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, additional trusted alternate for therapeutic use,